Gene · 4627
Papers4,242
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 4,242
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The role of molecular subtypes and immune infiltration characteristics based on disulfidptosis-associated genes in lung adenocarcinoma. | Aging (Albany NY) | 2023 | 37315289 | PubTator, text mining | PubMed |
| A non-muscle myosin heavy chain 9 genetic variant is associated with graft failure following kidney transplantation. | Kidney Res Clin Pract | 2023 | 37313613 | PubTator, text mining | PubMed |
| Prediction of prognosis and immunotherapy response in breast cancer based on neutrophil extracellular traps-related classification. | Front Mol Biosci | 2023 | 37304069 | PubTator, text mining | PubMed |
| Next-Generation Sequencing and Triple-Negative Breast Cancer: Insights and Applications. | Int J Mol Sci | 2023 | 37298642 | PubTator, text mining | PubMed |
| The cochlea is built to last a lifetime. | Hear Res | 2023 | 37295280 | PubTator, text mining | PubMed |
| Infiltrating myeloid cell diversity determines oncological characteristics and clinical outcomes in breast cancer. | Breast Cancer Res | 2023 | 37287069 | PubTator, text mining | PubMed |
| Mechanical force drives the initial mesenchymal-epithelial interaction during skin organoid development. | Theranostics | 2023 | 37284452 | PubTator, text mining | PubMed |
| Successful Kidney Transplantation in MYH-9-Related Disease Presenting with Severe Macrothrombocytopenia | Turk J Haematol | 2023 | 37278342 | PubTator, text mining | PubMed |
Identifying primary and secondary MLH1 epimutation carriers displaying low-level constitutional MLH1 methylation using droplet digital PCR and genome-wide DNA methylation profiling of colorectal cancers. | Clin Epigenetics | 2023 | 37270516 | PubTator, text mining | PubMed |
| Lipid droplet-associated lncRNA LIPTER preserves cardiac lipid metabolism. | Nat Cell Biol | 2023 | 37264180 | PubTator, text mining | PubMed |
| Successful living-related kidney transplantation in MYH9-related disorder with macrothrombocytopenia: lessons for the clinical nephrologist. | J Nephrol | 2023 | 37258992 | PubTator, text mining | PubMed |
| Emerging Therapies and Advances in Sickle Cell Disease with a Focus on Renal Manifestations. | Kidney360 | 2023 | 37254256 | PubTator, text mining | PubMed |
| Comprehensively prognostic and immunological analysis of snail family transcriptional repressor 2 in pan-cancer and identification in pancreatic carcinoma. | Front Immunol | 2023 | 37251370 | PubTator, text mining | PubMed |
| Impairment of rigidity sensing caused by mutant TP53 gain of function in osteosarcoma. | Bone Res | 2023 | 37246175 | PubTator, text mining | PubMed |
| Broad-Spectrum Antivirals Derived from Natural Products. | Viruses | 2023 | 37243186 | PubTator, text mining | PubMed |
| Identification of Potential Inflammation-Related Genes and Key Pathways Associated with Complex Regional Pain Syndrome. | Biomolecules | 2023 | 37238642 | PubTator, text mining | PubMed |
| Diagnostic rate of germline pathogenic variants in pancreatic ductal adenocarcinoma patients using whole genome sequencing. | Front Genet | 2023 | 37234870 | PubTator, text mining | PubMed |
| Mesenchymal Tumors of the Breast: Fibroblastic/Myofibroblastic Lesions and Other Lesions. | Curr Oncol | 2023 | 37232796 | PubTator, text mining | PubMed |
| Usenamine A induces apoptosis and autophagic cell death of human hepatoma cells via interference with the Myosin-9/actin-dependent cytoskeleton remodeling. | Phytomedicine | 2023 | 37229890 | PubTator, text mining | PubMed |
| Regulation of hematopoietic stem cells differentiation, self-renewal, and quiescence through the mTOR signaling pathway. | Front Cell Dev Biol | 2023 | 37228652 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4627/papers?page=28